AVE 33.3% 0.2¢ avecho biotechnology limited

Like you Halfull I'm not happy about my holding diluted more...

  1. 5,322 Posts.
    Like you Halfull I'm not happy about my holding diluted more than 20% today- but to suggest this is because the acne trials look bad is wildly speculative and I doubt in any way accurate. 2nd the OxyM trials are still running as per schedule advised at the AGM in May. No Pharma deal will happen before a Phase 2 is completed so anyone worrying that an early CR is a sign of lack of interest from Pharma is plain wrong . I agree with GC that this should be our last CR ( and yes I've said that before so I'm an idiot)... POH however is now so tantalisingly close to success that this is the time to hold tight
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.